Applied NeuroSolutions biomarker may predict Alzheimer's disease progression
A recent study published in Archives of Neurology suggests that variations in p-tau 231 levels can predict the structural progression of Alzheimer's disease. The biomarker has been shown to discriminate between AD patients and those with other neurodegenerative disorders, with high accuracy in detecting early-stage disease.